SEC Filings

Form 10-K
ORGANOVO HOLDINGS, INC. filed this Form 10-K on 06/10/2014
Document Outline
Entire Document (3281.7 KB)
Subdocument 1 - 10-K - 10-K
Page 1 - UNITED STATES
Page 2 - Organovo Holdings, Inc.
Page 3 - Important Information Regarding Forward-Looking Statements
Page 4 - PART I
Page 5 - Our Market Opportunity
Page 6 - Background on Bioprinting
Page 7 - The NovoGen Bioprinter Platform
Page 8 - Research Collaborations
Page 9 - Our Product Candidates
Page 10 - in vitro
Page 11 - Forgacs Intellectual Property
Page 12 - Regulatory Considerations
Page 13 - Raw Materials
Page 14 - Item 1A. Risk Factors
Page 15 - We may not be able to correctly estimate our future revenues and operating expenses, which could lea
Page 16 - Our technology, tools and products are subject to the risks associated with new and rapidly evolving
Page 17 - We cannot control our collaborators allocation of resources or the amount of time that our collabora
Page 18 - We face intense competition which could result in reduced acceptance and demand for our research too
Page 19 - We will require access to a constant, steady, reliable supply of human cells to successfully commerc
Page 20 - An inability to manage our planned growth or expansion of our operations could adversely affect our
Page 21 - N/A
Page 22 - If restrictions on reimbursements and health care reform limit our collaborators actual or potential
Page 23 - We may not be able to protect our intellectual property rights in the United States.
Page 24 - We may be involved in lawsuits or other proceedings to protect or enforce our patents or the patents
Page 25 - inter partes
Page 26 - Risks Related to Our Common Stock and Liquidity Risks
Page 27 - The price of our common stock may continue to be volatile, which could lead to losses by investors a
Page 28 - Our common stock is controlled by insiders.
Page 29 - Item 1B. Unresolved Staff Comments.
Page 30 - PART II
Page 31 - Performance Graph
Page 32 - Equity Compensation Plans
Page 33 - Item 6. Selected Financial Data (in thousands except per share data)
Page 34 - Item 7. Management s Discussion and Analysis of Financial Condition and Results of Operations.
Page 35 - Critical Accounting Policies
Page 36 - Product Revenue
Page 37 - Allowance for Doubtful Accounts
Page 38 - Stock-Based Compensation
Page 39 - Research and Development Expenses
Page 40 - Comparison of the three months ended March 31, 2013 and 2012
Page 41 - Comparison of the years ended December 31, 2012 and 2011
Page 42 - Other Income (Expense)
Page 43 - N/A
Page 44 - Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
Page 45 - Item 8. Consolidated Financial Statements and Supplementary Data
Page 46 - Report of Independent Registered Public Accounting Firm
Page 47 - Report of Independent Registered Public Accounting Firm
Page 48 - ORGANOVO HOLDINGS, INC.
Page 49 - ORGANOVO HOLDINGS, INC.
Page 50 - ORGANOVO HOLDINGS, INC.
Page 51 - ORGANOVO HOLDINGS, INC.
Page 52 - Supplemental Disclosure of Noncash Investing and Financing Activities ($ in thousands):
Page 53 - Organovo Holdings, Inc.
Page 54 - NYSE MKT Listing
Page 55 - Use of estimates
Page 56 - Restricted cash
Page 57 - N/A
Page 58 - Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Page 59 - N/A
Page 60 - Stock-based compensation
Page 61 - Comprehensive income (loss)
Page 62 - 4. Accrued Expenses
Page 63 - 6. Convertible Notes Payable
Page 64 - Local Bridge
Page 65 - 2012 Private placement
Page 66 - Registration rights agreement
Page 67 - Restricted stock awards
Page 68 - N/A
Page 69 - N/A
Page 70 - Stock options
Page 71 - Warrants
Page 72 - N/A
Page 73 - Common stock reserved for future issuance
Page 74 - Capital leases
Page 75 - Legal Matters
Page 76 - Other Legal Matters
Page 77 - Clemson University
Page 78 - 10. Income Taxes
Page 79 - 11. Concentrations
Page 80 - Disclosure Controls and Procedures
Page 81 - Inherent Limitations on Effectiveness of Controls
Page 82 - N/A
Page 83 - PART III
Page 84 - PART IV
Page 85 - SIGNATURES
Page 86 - EXHIBIT INDEX
Page 87 - N/A
Page 88 - N/A
Page 89 - Exhibit No.
Subdocument 2 - EX-23.1 - EX-23.1
Page 1 - Exhibit 23.1
Subdocument 3 - EX-31.1 - EX-31.1
Page 1 - Exhibit 31.1
Subdocument 4 - EX-31.2 - EX-31.2
Page 1 - Exhibit 31.2
Subdocument 5 - EX-32.1 - EX-32.1
Page 1 - Exhibit 32.1
XBRL Item - EX-101.INS - XBRL INSTANCE DOCUMENT (What's this?)
XBRL Item - EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA (What's this?)
XBRL Item - EX-101.CAL - XBRL TAXONOMY EXTENSION CALCULATION LINKBASE (What's this?)
XBRL Item - EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE (What's this?)
XBRL Item - EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE (What's this?)
XBRL Item - EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE (What's this?)
XBRL Viewer
Print Page Print Page | E-mail Page Email Page | RSS Feeds RSS Feeds | IR Contacts Investor Contacts | Financial Tear Sheet Financial Tear Sheet